Join the DDA or

M&A Pharmachem paracetamol recall

Possible fungal contamination

November 28th 2019

Tagged: MHRA alert


M&A Pharmachem is recalling paracetamol 500mg tablets x 1000 as a precautionary measure: a small number of pots from some batches have been found to contain discoloured tablets due to fungal contamination. The fungus has been identified as Penicillium citrinum.

Healthcare professionals are advised to quarantine all remaining stock and return it to the supplier using your supplier’s approved process. It is considered unlikely that any affected tablets will have got to patient level as the discolouration is noticeable on opening affected packs.

For stock enquiries, please contact Pauline Caddick, Responsible Person:

For medical information enquiries, please contact Cristina Parau, Pharmacovigilance Manager

For all the latest news of the 2020 DDA annual conference...

Learn more